Tue, Dec 23, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Atalaya Capital closes oversubscribed fifth special opportunities fund

Wednesday, August 14, 2013

Komfie Manalo, Opalesque Asia:

Alternative investment and New York-based Atalaya Capital Management has closed its fifth special opportunities fund offering to a new and existing primarily institutional investor base after the management team quickly exceeded the $500m target.

The fund held its first and final close on August 1st at Atalaya Fund V’s self-imposed hard-cap of $575m. The firm said Atalaya Fund V will seek to build upon the firm’s prior success in opportunistically purchasing illiquid credit assets. Fund V may also invest in specialty finance opportunities and originate select primary private credit investments.

"We are pleased that Fund V, like its predecessor, Fund IV, significantly exceeded its target raise, demonstrating the continued attractiveness of the private credit opportunity set to both existing investors and new participants," said Ivan Q. Zinn, Atalaya’s Founding Partner and Chief Investment Officer.

He went on to say, "Atalaya’s ability and willingness to transact at smaller investment sizes continues to provide us with many attractive investment opportunities. We remain committed to this range of the opportunity spectrum, and believe that our disciplined focus will continue to reward our investors."

Atalaya initiated fundraising for the new vehicle during the first quarter of 2013 after drawing down over 70% of Fund IV’s $500m in commitments. The commit......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its